Акціонерне Товариство Закритого Типу "Фармацевтична Фірма "Фаркос"
Акционерное Общество Закрытого Типа "Фармацевтическая Фирма "Фаркос"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Акціонерне Товариство Закритого Типу "Фармацевтична Фірма "Фаркос", Акционерное Общество Закрытого Типа "Фармацевтическая Фирма "Фаркос"filedCriticalАкціонерне Товариство Закритого Типу "Фармацевтична Фірма "Фаркос"
Priority to UA99020840ApriorityCriticalpatent/UA43797A/en
Priority to RU99105304/14Aprioritypatent/RU2190411C2/en
Publication of UA43797ApublicationCriticalpatent/UA43797A/en
The injection form of preparation on basis adenosin -5'-triphosphat in the isotonic solution, that manifests anti-ischemic activity is described. As the source of adenosin -5'-triphosphat it contains tripotassium salt adenosin -5'-triphosphat histidinatomagnesium (II) octahydrate and additionally contains pharmaceutical acceptable organic either inorganic acid or their salts in the quantity necessary for achievement of pH 7,0-7,4.
UA99020840A1999-02-151999-02-15Injection form of the preparation, which manifests the anti-ischemic activity
UA43797A
(en)